NCT04889599View on ClinicalTrials.gov

A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours

PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

April 29, 2021

Primary Completion Date

September 17, 2021

Study Completion Date

September 24, 2021

Conditions
DocetaxelSolid TumoursBioequivalence
Interventions
DRUG

BH009 (Docetaxel injection)

75mg/m2

DRUG

Docetaxel injection

75mg/m2

Trial Locations (3)

Unknown

HCG City Cancer center, Āndra

Nirmal Hospital Pvt. Ltd, Gujrāt

HCG Manavata Cancer Centre, Mahara

All Listed Sponsors
lead

Zhuhai Beihai Biotech Co., Ltd

INDUSTRY